Omeros (OMER) Net Income Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.59% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -115.33% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -73.01% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 17.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.20% |
| Dec 31, 2025 | 26.59% |
| Sep 30, 2025 | -298.20% |
| Jun 30, 2025 | -94.87% |
| Mar 31, 2025 | -38.42% |
| Dec 31, 2024 | -82.85% |
| Sep 30, 2024 | -64.90% |
| Jun 30, 2024 | 29.77% |
| Mar 31, 2024 | 11.43% |
| Dec 31, 2023 | -82.71% |
| Sep 30, 2023 | -62.75% |
| Jun 30, 2023 | -35.46% |
| Mar 31, 2023 | -7.73% |
| Dec 31, 2022 | -46.70% |
| Sep 30, 2022 | 73.05% |
| Jun 30, 2022 | -49.77% |
| Mar 31, 2022 | -55.83% |
| Dec 31, 2021 | 553.57% |
| Sep 30, 2021 | 156.09% |
| Jun 30, 2021 | 164.16% |
| Mar 31, 2021 | 149.62% |
| Dec 31, 2020 | 35.38% |
| Sep 30, 2020 | -133.63% |
| Jun 30, 2020 | -126.38% |
| Mar 31, 2020 | -19.09% |
| Dec 31, 2019 | -373.63% |
| Sep 30, 2019 | 58.89% |
| Jun 30, 2019 | 56.64% |
| Mar 31, 2019 | 18.60% |
| Dec 31, 2018 | -39.08% |
| Sep 30, 2018 | -407.53% |
| Jun 30, 2018 | -133.89% |
| Mar 31, 2018 | -98.30% |
| Dec 31, 2017 | -18.70% |
| Sep 30, 2017 | 44.33% |
| Jun 30, 2017 | -14.67% |
| Mar 31, 2017 | 26.12% |
| Dec 31, 2016 | 24.08% |
| Sep 30, 2016 | 29.74% |
| Jun 30, 2016 | 24.36% |
| Mar 31, 2016 | -10.27% |
| Dec 31, 2015 | 10.65% |
| Sep 30, 2015 | -11.61% |
| Jun 30, 2015 | 6.87% |
| Mar 31, 2015 | -15.49% |
| Dec 31, 2014 | -51.50% |
| Sep 30, 2014 | -28.87% |
| Jun 30, 2014 | -32.04% |
| Mar 31, 2014 | -54.27% |
| Dec 31, 2013 | -76.39% |
| Sep 30, 2013 | -4.38% |
| Jun 30, 2013 | -58.18% |
| Mar 31, 2013 | -23.93% |
| Dec 31, 2012 | 23.89% |
| Sep 30, 2012 | -101.03% |
| Jun 30, 2012 | -59.12% |
| Mar 31, 2012 | -27.18% |
| Dec 31, 2011 | -17.22% |
| Sep 30, 2011 | 13.70% |
| Jun 30, 2011 | 31.91% |